Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-11-18
1988-04-12
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544346, A61K 3148, C07D51902
Patent
active
047374993
ABSTRACT:
An ergot 5'S-(2R-butyl) peptide alkaloid and its acid addition salts is a useful pharmaceutical for use as a prolactin secretion inhibitor, for increasing vigilance or for the treatment of senile dementia, hypertension, or stroke.
REFERENCES:
patent: 4000139 (1976-12-01), Stutz et al.
patent: 4091099 (1978-05-01), Fehr et al.
patent: 4138565 (1979-02-01), Ehrhardt et al.
Daus Donald G.
Honor Robert S.
McGovern Thomas O.
Sandoz Ltd.
Sharkin Gerald D.
LandOfFree
Ergotalkaloids for treating senile dementia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ergotalkaloids for treating senile dementia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ergotalkaloids for treating senile dementia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1429539